Pluristem Therapeutics, Inc. (NASDAQ:PSTI)

CAPS Rating: 1 out of 5

Results 1 - 9 of 9

Recs

0
Member Avatar SnarkyApple (48.37) Submitted: 9/13/2012 11:41:00 PM : Underperform Start Price: $3.90 PSTI Score: +60.44

Shenanigans.

Recs

0
Member Avatar shaito (< 20) Submitted: 8/20/2012 1:07:19 AM : Outperform Start Price: $3.98 PSTI Score: -66.62

the stock its in her lower price and other company with the same prodact without any life saver like psti the stoock need to be like 7-8 dollars

Recs

0
Member Avatar dolpho2 (< 20) Submitted: 8/17/2012 4:06:30 PM : Outperform Start Price: $3.98 PSTI Score: -66.62

Their technology seems to work. PLX-PAD is the only drug that heals the heart muscle instead of just prolonging life. Their drug for aplastic anaemia has been given to two people in a tel aviv hospital under Israel's compassion rule for terminal patients and both have survived. Looks like exciting work in their "snake oil". People seem to be scared of any new technology and will wait until they have a product on the market, missing the big run up (or down) during the development.

Recs

0
Member Avatar SuzaAdam (< 20) Submitted: 8/17/2012 3:35:08 PM : Outperform Start Price: $4.16 PSTI Score: -69.77

Superior technology

Recs

0
Member Avatar txboy70 (< 20) Submitted: 8/6/2012 10:28:36 PM : Outperform Start Price: $3.78 PSTI Score: -64.38

biotech has not been as tied to broad market ups and downs.
It is tied to the performance of it's product. PSTI has a product
which has MANY uses,not a one trick poney. It is patented and
is readily repeatable. delivery is simple. the drug stores well in
the typical medical office.

Recs

0
Member Avatar Ronsevet (< 20) Submitted: 3/29/2012 3:34:28 AM : Outperform Start Price: $2.21 PSTI Score: -10.20

A very well oriented stem company, with technological aspirations well in the realm of reality, extended their bioreactor capabilities just now,two phase two trials to be released in the near future with nice track record behind them.

Recs

0
Member Avatar Zippany (< 20) Submitted: 4/4/2011 12:10:46 PM : Outperform Start Price: $2.73 PSTI Score: -40.30

Cell therapeutics derived from placenta. Proprietary bioreactor. Based in Israel.

Recs

0
Member Avatar dgoldmeier (21.47) Submitted: 3/4/2011 4:30:52 PM : Outperform Start Price: $2.33 PSTI Score: -24.27

needs time and money to develop, but if it is sucsessfull will become a billion + powerhouse.

Recs

0
Member Avatar NanoORBust (< 20) Submitted: 2/3/2011 5:41:51 PM : Outperform Start Price: $2.98 PSTI Score: -53.93

Seems to be following that pattern set by Mesoblast only with a much smaller market cap.

Results 1 - 9 of 9

Featured Broker Partners


Advertisement